Back to Journals » OncoTargets and Therapy

SJR OA
CiteScore
Impact Factor

OncoTargets and Therapy

ISSN: 1178-6930


       

Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Case report

A Rare Histologic Transformation from EGFR-Positive Lung Adenocarcinoma to EGFR-Negative Squamous Cell Carcinoma After EGFR-TKIs Resistance: A Case Report

Qiu M, Guo P, Lin J, Wang S, Wang W, Yang J, Huang Z, Cao Y

OncoTargets and Therapy 2025, 18:803-809

Published Date: 18 July 2025

Original Research

Biomarker and Prognostic Value of Super-ARMS Detection for EGFR Mutation in Advanced NSCLC

Liu H, Li H, Xiao L, Guo Y, Lin G

OncoTargets and Therapy 2025, 18:789-801

Published Date: 8 July 2025

Review

The Potential Role and Effective Components of Sanyeqing as the Potential Therapeutic Candidates for IBD and CRC

Chen C, Chen L, Zheng W, Dai Y

OncoTargets and Therapy 2025, 18:779-788

Published Date: 7 July 2025

Original Research

Multi‑cohort Validation Based on Disulfidptosis-Related lncRNAs for Predicting Prognosis and Immunotherapy Response of Esophageal Squamous Cell Carcinoma

Yi Z, Li X, Li Y, Ji Y, Zhao J, Xu H, Zhou L, Song J

OncoTargets and Therapy 2025, 18:763-778

Published Date: 25 June 2025

Original Research

Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy

Chuang TI, Hsu KH, Lee PH, Tseng JS, Hsu YW, Liao CH, Huang YH, Yang TY

OncoTargets and Therapy 2025, 18:751-761

Published Date: 25 June 2025


Read more articles